- Home
- EXK vs TARS Comparison
EXK vs TARS Comparison
Compare EXK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXK | TARS |
|---|---|---|
| Founded | 1981 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | EXK | TARS |
|---|---|---|
| Price | $11.59 | $71.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $13.31 | ★ $76.56 |
| AVG Volume (30 Days) | ★ 14.9M | 709.0K |
| Earning Date | 03-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $337,137,000.00 | ★ $366,100,000.00 |
| Revenue This Year | $111.57 | $147.34 |
| Revenue Next Year | $64.09 | $53.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 49.22 | ★ 182.44 |
| 52 Week Low | $2.95 | $38.51 |
| 52 Week High | $11.72 | $85.25 |
Technical Indicators
Market Signals| Indicator | EXK | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 67.59 | 26.51 |
| Support Level | $9.37 | $76.91 |
| Resistance Level | $10.60 | $76.22 |
| Average True Range (ATR) | 0.77 | 3.15 |
| MACD | 0.14 | -1.09 |
| Stochastic Oscillator | 96.16 | 0.12 |
Price Performance
Historical ComparisonAbout EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.